With advancements in medical technology and the introduction of new drugs in recent years, the survival rate and life expectancy of cancer patients have significantly increased. Cancer used to be a dreaded disease, but has now gradually transformed into a chronic illness. However, as treatments improve, cancer cells also begin to develop resistance to treatment, leading to a long battle with researchers.
To bring hope to cancer patients, it is crucial for patients and the public to actively participate in clinical trial recruitment. Clinical trials help healthcare professionals address the challenges they face in treating patients and accelerate the development of new cancer drugs that can be used for different types and stages of cancer, enabling healthcare professionals to use new drugs to defeat cancer.
In Hong Kong, clinical trials are typically conducted in different hospitals or medical centres. Prospective participants must meet the recruitment criteria of the clinical trial and undergo a rigorous screening process to participate.
We are currently recruiting qualified patients to participate in the following clinical studies. If you are interested and would like to know your eligibility to participate, please contact our staff for more information:
If you want to learn about other clinical trials that are currently recruiting in Hong Kong, you can visit the websites of university Clinical Trial Centres below:
The development of new drugs is a lengthy process. In the early stages of development, researchers need to conduct a series of complex studies and tests in the laboratory, including testing on animals, to understand the drug’s effects on a living organism. Before a new drug is released on the market, researchers need to evaluate its effectiveness in humans through clinical trials. Researchers use pharmacokinetic modelling to calculate the lowest effective dose for human use and ensure the safety of clinical trials. Data shows that new cancer drugs developed through clinical trials have significantly improved patient outcomes.
Due to the different methods used to verify pharmacology, effectiveness, and safety, clinical trials are usually divided into several phases to find answers to different questions. Generally speaking, clinical trials can be divided into four phases.
|Phase 1||Phase 2||Phase 3||Phase 4|
|Purpose||Explore the pharmacology and safety of the drug. Find the highest dose suitable for use in humans, without causing serious side effects.||Evaluate the effectiveness and safety of the drug at different doses.||Compare the efficacy and safety of new drugs with conventional treatment options or placebo. Some phase III clinical trials will also investigate the impact of new drugs on patients’ quality of life.||Evaluate the conditions in which patients take the drug after it is launched on the market, including the long-term efficacy and side effects of the drug.|
|Recruitment target group||Healthy adults. Some clinical trials will also recruit patients, mainly cancer patients. Some drugs will be tested on patients with different types of cancer.||Patients for which the drug is indicated.||Patients for which the drug is indicated.||Patients who are currently taking the drug or have already ceased taking the drug.|
|Number of recruits||Within 100||Several hundred||Several thousand||Tens of thousands|
Clinical Trials Recruitment allows patients to receive cutting-edge treatments that may not be available through standard care and clinical protocols. Clinical trials provide access to new drugs and treatments that can potentially improve patient outcomes and quality of life. Additionally, Clinical Trials Recruitment helps to advance medical knowledge and improve treatments for future patients.
The content above has been reviewed by our medical team. It is provided for reference only and cannot replace the opinion given by medical professionals.
Last reviewed on: 10 March 2021
Translated on: 20 April 2023